Fat-Bone Relationship in Chronic Kidney Disease-Mineral Bone Disorders: Adiponectin Is Associated with Skeletal Events among Hemodialysis Patients.
Po-Cheng ChenShu-Wei ChangChih-Yu HsiehJian-Chiun LiouJia-Feng ChangTing-Ming WangPublished in: Diagnostics (Basel, Switzerland) (2021)
Adiponectin was associated with an incremental risk of BF that could serve as a potential predictor of BF in MHD patients. In the high-risk population with hyperphosphatemia, an elevated adiponectin level could alert clinicians to the urgent need to correct mineral dysregulation and undertake further bone survey.
Keyphrases
- bone mineral density
- metabolic syndrome
- end stage renal disease
- insulin resistance
- soft tissue
- newly diagnosed
- bone loss
- bone regeneration
- ejection fraction
- chronic kidney disease
- peritoneal dialysis
- prognostic factors
- type diabetes
- fatty acid
- clinical decision support
- risk assessment
- human health
- electronic health record